Julie Fuller, the Executive Vice President of Zoetis Inc., has reported a transaction involving phantom stock units in a recent SEC filing. This transaction, dated October 9, 2026, is significant as it highlights the ongoing compensation practices for executives in the pharmaceutical sector.
Zoetis Inc., known for its focus on animal health, operates under the Central Index Key (CIK) number 0001555280. The company is categorized under the Standard Industrial Classification (SIC) for Pharmaceutical Preparations. This filing is part of a series of recent disclosures, with the latest being submitted on October 13, 2026.
In the filing, Fuller acquired 367.7876 phantom stock units at a price of $26.17 each. Following this transaction, she now holds a total of 2,480.4695 shares. The filing noted that these phantom stock units are settled in cash after the reporting person's separation from service, and they may be transferred into alternative investment funds under certain conditions.
This transaction may affect various stakeholders, including Zoetis investors and employees, as it reflects the company's approach to executive compensation and retention strategies. The pharmaceutical industry often sees such practices as a way to align executive interests with shareholder value.
The filing does not say what happens next.
Additional Details on Phantom Stock Units
The phantom stock units acquired by Julie Fuller are part of the Zoetis Supplemental Savings Plan. Each unit represents a fraction of a phantom share of Zoetis common stock, along with a small amount of cash-equivalent investments, which typically accounts for around 5% of the total value of the phantom stock unit. This structure ties the value of the phantom stock units to the market performance of Zoetis common stock.
Furthermore, the filing indicates that the phantom stock units may be transferred into alternative investment funds at any time, although Zoetis retains the right to limit the timing, frequency, and permissibility of such transfers. This provision provides flexibility for executives in managing their investments while still aligning their interests with the company's performance.
"These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service."
As of the filing date, Julie Fuller holds a total of 2,480.4695 shares after this transaction, which reflects her ongoing commitment to the company and its strategic direction.